Oracle stock price falls after-hours as tariff jitters fade, but ORCL still lags market rebound
21 January 2026
1 min read

Oracle stock price falls after-hours as tariff jitters fade, but ORCL still lags market rebound

New York, Jan 21, 2026, 16:42 ET — After-hours

  • Oracle shares dropped roughly 3% after the close, marking their second consecutive session of losses.
  • Wall Street closed up after Trump indicated tariffs linked to Greenland wouldn’t kick in on Feb. 1.
  • A Guggenheim analyst kept a $400 price target on Oracle, labeling it a “decade stock.”

Oracle shares dropped 3.4% to $173.88 in after-hours trading Wednesday, continuing their slide despite a late-day bounce in the broader U.S. market.

This shift is significant since Oracle now serves as a high-beta indicator for sentiment on major cloud and AI infrastructure investments, and geopolitical jitters have rattled the market once more. Wednesday’s split—stocks climbing while Oracle slipped—highlighted how fast investors are toggling between “AI buildout” leaders and concerns over balance sheets.

Wall Street’s major indexes climbed as President Donald Trump announced a framework deal on Greenland that would prevent tariffs scheduled for Feb. 1, boosting risk appetite into the final hour. 1

Oracle didn’t keep pace. Shares swung between $170.83 and $182.50 during the session, with volume topping 37 million, market data shows.

Some of the selling stemmed from Tuesday’s broad decline, which saw tariff fears drag the S&P 500 and Nasdaq beneath their 50-day moving averages, sparking a jump in volatility. 2

“The geopolitical risks … are re-emerging,” said Wasif Latif, chief investment officer at Sarmaya Partners, on Tuesday, noting a risk-off mood that spilled over into Japan’s government bond market. 3

Oracle dropped 5.85% Tuesday, closing at $179.92, then slid further on Wednesday, totaling about a 9% decline over two days. 4

One bull isn’t backing down despite the pullback. Guggenheim analyst John DiFucci stuck with a buy rating and a $400 price target on Oracle, calling it a potential “decade stock.” He believes the company is set to play a key role in AI infrastructure. 5

Investors are on edge over Oracle’s funding requirements and returns following the company’s recent outlook, which fell short of Wall Street’s expectations. The firm also warned of increased capital spending linked to its AI cloud expansion. 6

There’s a risk, though. If tariff threats resurface, borrowing costs remain high, or demand for big AI capacity contracts cools off, companies requiring steady investment before seeing revenue gains could take another hit — Oracle falls into that group.

Traders are focused on Thursday’s EU emergency summit in Brussels, looking for any signs of escalation. They’ll also be keeping an eye on the Feb. 1 tariff deadline that Trump mentioned prior to Wednesday’s reversal. 3

Oracle is set to pay a quarterly cash dividend of $0.50 per share on Jan. 23. Investors will be watching closely for new details on financing and data-center strategies before the company’s next earnings report later this quarter. 7

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Netflix stock slides after hours as Warner Bros cash bid and 2026 outlook keep NFLX under pressure
Previous Story

Netflix stock slides after hours as Warner Bros cash bid and 2026 outlook keep NFLX under pressure

Amazon stock ends flat after Jassy warns tariffs are creeping into prices
Next Story

Amazon stock ends flat after Jassy warns tariffs are creeping into prices

Go toTop